{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:55:39Z","timestamp":1778824539127,"version":"3.51.4"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T00:00:00Z","timestamp":1316044800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024240","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T04:01:17Z","timestamp":1316145677000},"page":"e24240","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Correlation of Circulating Omentin-1 with Bone Mineral Density in Multiple Sclerosis: The Crosstalk between Bone and Adipose Tissue"],"prefix":"10.1371","volume":"6","author":[{"given":"Majid","family":"Assadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hooman","family":"Salimipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samad","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Mojtaba","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshar","family":"Bargahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Samani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Seyedabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Sanjdideh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Nabipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,9,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/er.2006-0033","article-title":"Adipose tissue-derived factors: impact on health and disease.","volume":"27","author":"ME Trujillo","year":"2006","journal-title":"Endocr Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2009.04.004","article-title":"A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms.","volume":"310","author":"CB Confavreux","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.","volume":"100","author":"P Ducy","year":"2000","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1359\/jbmr.060707","article-title":"Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.","volume":"21","author":"XH Luo","year":"2006","journal-title":"J Bone Miner Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbaexp.2005.11.005","article-title":"Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue.","volume":"1732","author":"A Schaffler","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.","volume":"290","author":"RZ Yang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/db06-1506","article-title":"Omentin plasma levels and gene expression are decreased in obesity.","volume":"56","author":"CM de Souza Batista","year":"2007","journal-title":"Diabetes"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/db07-0990","article-title":"Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.","volume":"57","author":"BK Tan","year":"2008","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-7-27","article-title":"Circulating omentin concentration increases after weight loss.","volume":"7","author":"JM Moreno-Navarrete","year":"2010","journal-title":"Nutr Metab (Lond)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1517\/13543784.17.3.327","article-title":"Vaspin: a novel serpin with insulin-sensitizing effects.","volume":"17","author":"J Wada","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity.","volume":"A102","author":"K Hida","year":"2005","journal-title":"Proc Natl Acad Sci U S"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1189\/jlb.0108022","article-title":"The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?","volume":"84","author":"G Matarese","year":"2008","journal-title":"J Leukoc Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/JME-08-0131","article-title":"Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases.","volume":"43","author":"R Gomez","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ncprheum0674","article-title":"Adipokines as emerging mediators of immune response and inflammation.","volume":"3","author":"F Lago","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/157339508784325046","article-title":"Leptin and Inflammation.","volume":"4","author":"N Iikuni","year":"2008","journal-title":"Curr Immunol Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0165-5728(03)00154-1","article-title":"Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta.","volume":"139","author":"AP Batocchi","year":"2003","journal-title":"J Neuroimmunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.4049\/jimmunol.166.10.5909","article-title":"Requirement for leptin in the induction and progression of autoimmune encephalomyelitis.","volume":"166","author":"G Matarese","year":"2001","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1073\/pnas.0408995102","article-title":"Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.","volume":"102","author":"G Matarese","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.","volume":"50","author":"WI McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).","volume":"33","author":"JF Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jcb.20890","article-title":"Regulation of bone formation by adiponectin through autocrine\/paracrine and endocrine pathways.","volume":"99","author":"Y Shinoda","year":"2006","journal-title":"J Cell Biochem"},{"key":"ref22","first-page":"522","article-title":"Molecular aspects of adipokine-bone interactions.","volume":"10","author":"P Magni","year":"2010","journal-title":"Curr Mol Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00415-008-6001-2","article-title":"Pathophysiology of multiple sclerosis.","volume":"255","author":"T Korn","year":"2008","journal-title":"J Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI12980","article-title":"Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.","volume":"107","author":"DT Denhardt","year":"2001","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jneuroim.2004.09.004","article-title":"Plasma osteopontin levels in multiple sclerosis.","volume":"158","author":"M Comabella","year":"2005","journal-title":"J Neuroimmunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/qjmed\/95.1.3","article-title":"Osteopontin\u2013a molecule for all seasons.","volume":"95","author":"M Mazzali","year":"2002","journal-title":"QJM"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.10606","article-title":"Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.","volume":"53","author":"MH Vogt","year":"2003","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2004.06.007","article-title":"Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients.","volume":"155","author":"MH Vogt","year":"2004","journal-title":"J Neuroimmunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-009-1107-7","article-title":"Increased serum osteopontin is a risk factor for osteoporosis in menopausal women.","volume":"21","author":"IC Chang","year":"2010","journal-title":"Osteoporos Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/1352458509359723","article-title":"Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers.","volume":"16","author":"MH Vogt","year":"2010","journal-title":"Mult Scler"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2008.08.031","article-title":"The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis?","volume":"276","author":"A Altintas","year":"2009","journal-title":"J Neurol Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/ATVBAHA.110.204859","article-title":"Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome.","volume":"30","author":"U Saleem","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton.","volume":"130","author":"NK Lee","year":"2007","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e4952","DOI":"10.1371\/journal.pone.0004952","article-title":"Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis.","volume":"4","author":"SA Shiryaev","year":"2009","journal-title":"PLoS One"},{"issue":"Pt 2","key":"ref35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/brain\/122.2.191","article-title":"Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.","volume":"122","author":"MA Lee","year":"1999","journal-title":"Brain"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-5728(99)00094-6","article-title":"Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis.","volume":"99","author":"R Lichtinghagen","year":"1999","journal-title":"J Neuroimmunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1212\/01.WNL.0000167129.90918.f5","article-title":"High sensitivity measurement of CRP and disease progression in multiple sclerosis.","volume":"65","author":"M Soilu-Hanninen","year":"2005","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/gme.0b013e3181a181b8","article-title":"Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.","volume":"16","author":"I Nabipour","year":"2009","journal-title":"Menopause"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.0000165119.62099.14","article-title":"Dysregulated osteoprotegerin\/RANK ligand\/RANK axis in clinical and experimental heart failure.","volume":"111","author":"T Ueland","year":"2005","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00774-009-0089-z","article-title":"Osteoclasts and the immune system.","volume":"27","author":"T Nakashima","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"ref41","first-page":"431","article-title":"Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin levels in multiple sclerosis.","volume":"14","author":"S Kurban","year":"2008","journal-title":"Mult Scler"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1212\/WNL.0b013e3181beece8","article-title":"A cross-sectional study of bone health in multiple sclerosis.","volume":"73","author":"RA Marrie","year":"2009","journal-title":"Neurology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1682\/JRRD.2007.10.0159","article-title":"Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition.","volume":"45","author":"MC Mojtahedi","year":"2008","journal-title":"J Rehabil Res Dev"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2009.09.012","article-title":"Multiple sclerosis, osteoporosis, and vitamin D.","volume":"287","author":"C Sioka","year":"2009","journal-title":"J Neurol Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00415-009-5337-6","article-title":"Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.","volume":"257","author":"LH Steffensen","year":"2010","journal-title":"J Neurol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00774-005-0604-9","article-title":"Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity.","volume":"23","author":"S Ozgocmen","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jocn.2010.01.044","article-title":"Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.","volume":"17","author":"T Terzi","year":"2010","journal-title":"J Clin Neurosci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp.2006.105320","article-title":"A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.","volume":"79","author":"M Soilu-H\u00e4nninen","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref49","first-page":"72","article-title":"Vitamin D Deficiency in Iran: A Multi-center Study among Different Urban Areas.","volume":"1","author":"R Heshmat","year":"2008","journal-title":"Iranian J Publ Health"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T01:58:31Z","timestamp":1540259911000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024240"}},"subtitle":[],"editor":[{"given":"Markus","family":"Reindl","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,15]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024240","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,15]]}}}